pds0101
Generic: Versamune® HPV·Code: PDS0101
pds0101: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| PDS Biotechnology Corp (PDSB) | Phase 3 |
FDA Decisions
FDA_MeetingThe Company has requested a meeting with the FDA to explore an expedited approval pathway for PDS0101 in HPV16+ Head and Neck Cancer.(PDSB)
Frequently asked questions
Who is developing pds0101?
pds0101 is being developed by PDS Biotechnology Corp.
What is pds0101's latest FDA decision?
The most recent tracked FDA decision for pds0101 is FDA_Meeting for The Company has requested a meeting with the FDA to explore an expedited approval pathway for PDS0101 in HPV16+ Head and Neck Cancer..
Get deeper analysis on pds0101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis